1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. ESTABLISHMENT LABS HOLDINGS INC
Establishment Labs Holdings Inc
XNAS: ESTA
Momentum Trap
Download real time
66.472.41(3.76%)
31.89% Fall from 52W High
392.1K
XNAS Volume

XNAS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Establishment Labs Holdings Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Establishment Labs Holdings Inc share price target, revenues, EPS, net income and more

Establishment Labs Holdings Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Establishment Labs Holdings Inc Jun-2026 Quarterly Revenue is $68 Million which is growth of 31.7% YoY.

  • POSITIVE

    Quarterly Net Profit Establishment Labs Holdings Inc Jun-2026 Quarterly Net Profit is $-12 Million which is growth of 29.2% YoY.

Establishment Labs Holdings Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
67.559.964.653.851.341.444.540.244.137.231.638.548.6
Cost Of Rev.
19.817.519.116.11613.61414.515.212.81112.518.3
Gross Profit
47.742.345.537.735.327.830.525.728.924.420.626.130.3
⌄
5248.949.541.749.444.849.238.938.333.242.747.144
Operating Profit
-4.3-6.5-3.9-4-14.1-17-18.7-13.1-9.3-8.8-22.1-21-13.7
⌄
-7-7.1-7.2-6.2-5.9-5.6-5.8-5.1-4.6-3.9-3.8-3.4-3.5
Profit Before Tax
-11.7-13.1-11.9-10.7-15.6-19.8-35.9-16.2-16.8-15.8-23.1-28.6-15.8
Tax
00.3-9.30.410.9-1.40.50.40.4-2.50.70.9
⌄
-11.8-13.4-2.6-11.2-16.6-20.7-34.5-16.7-17.2-16.2-20.5-29.3-16.8
Diluted NI Avail to Com Stockholders Ann.
-11.8-13.4-2.6-11.2-16.6-20.7-34.5-16.7-17.2-16.2-20.5-29.3-16.8
Basic EPS
-0.4-0.5-0.1-0.4-0.6-0.7-1.2-0.6-0.6-0.6-0.8-1.1-0.7
Diluted EPS After ExtraOrdinary
-0.4-0.5-0.1-0.4-0.6-0.7-1.2-0.6-0.6-0.6-0.8-1.1-0.7
Number Of Shares End
30.13029.829.628.929.52928.327.927.826.12625.6
Net Income Continuing Discontinued Operations
-11.8-13.4-2.6-11.2-16.6-20.7-34.5-16.7-17.2-16.2-20.5-29.3-16.8
Normalized Income
-11.8-13.4-2.6-11.2-16.6-20.7-34.5-16.7-17.2-16.2-20.5-29.3-16.8
Interest Income
0000.10.10.30.20.20.60.50.50.30.2
Interest
77.17.26.265.965.35.24.44.33.73.6
Net Interest Income
-7-7.1-7.2-6.2-5.9-5.6-5.8-5.1-4.6-3.9-3.8-3.4-3.5
EBIT
-4.7-6-4.7-4.5-9.6-13.9-30-10.9-11.6-11.4-18.7-24.9-12.2
EBITDA
-2-3.3-1.9-2-7-11.4-27.6-8.7-10-10-17.3-23.7-11.1
Reconciled Cost Of Rev.
19.817.519.116.11613.61414.515.212.81112.518.3
Reconciled Depr.
2.72.72.82.52.62.62.42.21.61.41.41.21.1
Profit From Continuing Operations
-11.8-13.4-2.6-11.2-16.6-20.7-34.5-16.7-17.2-16.2-20.5-29.3-16.8
Normalized EBITDA
-2-3.3-1.9-2-7-11.4-27.6-8.7-10-10-17.3-23.7-11.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Establishment Labs Holdings Inc competitor comparison and performance snapshot within industry

Establishment Labs Holdings Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Establishment Labs Holdings Inc Dec-2025 Annual Revenue is $211 Million which is growth of 27.1% YoY.

  • POSITIVE

    Annual Net Profit Establishment Labs Holdings Inc Dec-2025 Annual Net Profit is $-51 Million which is growth of 39.6% YoY.

Establishment Labs Holdings Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16
⌄
9.3%
20%
 211.1166165.2161.7126.784.789.661.234.719.8
Cost Of Rev. Ann.
5.6%
15%
72.564.856.558.255.141.332.234.725.1179.7
Gross Profit Ann.
11.1%
22.7%
173.3146.3109.5107106.685.452.554.936.117.710.1
Operating Exp. Ann.
8.2%
18.2%
192185.3159.5172146.3110.580.485.86037.725.9
Operating Profit Ann.
-
-
-18.8-39-50-65-39.7-25.1-27.9-30.9-23.9-20-15.8
⌄
-
-
-27.4-24.8-19.4-14.4-11.7-9-9.4-8.7-8.8-10.4-3.4
Other Exp. Ann.
-
-
 5.8-15.30.8-21.5-5.5-0.72.111.8-4.4-2.8
PBT Ann.
-
-
-47.5-58-84.6-78.6-72.8-39.7-38-37.5-20.9-34.8-22
Tax Ann.
-
-
-8.6-7-0-0.12.41.40.10.60.20.10.1
⌄
-
-
-38.9-51.1-84.6-78.5-75.2-41.1-38.1-38.2-21.1-34.9-22.2
Diluted NI Avail to Com Stockholders Ann.
-
-
-38.9-51.1-84.6-78.5-75.2-41.1-38.1-38.2-21.1-34.9-22.2
EPS Ann.
-
-
 -1.7-3-3.1-3.1-1.7-1.6-1.9-1.2-1.9-1.2
Diluted EPS Ann.
-
-
 -1.7-3-3.1-3.1-1.7-1.6-1.9-1.2-1.9-1.2
Number Of Shares End
6.6%
4.7%
 29.82926.124.624.223.720.72115.4-
Total Exp. Ann.
7.5%
17.3%
 250.1216230.2201.4151.8112.6120.585.154.735.6
Net Income Continuing Discontinued Operations Ann.
-
-
-38.9-51.1-84.6-78.5-75.2-41.1-38.1-38.2-21.1-34.9-22.2
Normalized Income Ann.
-
-
-38.9-51.1-84.6-78.5-60.7-41.7-39.5-40.6-31.4-33.4-20.7
Interest Income Ann.
58.7%
-
0.10.41.510.100000
Interest Ann.
28.9%
21.9%
27.625.320.815.411.89.19.48.78.810.43.4
EBITDA Ann.
-
-
-9.2-22.3-56.2-58.3-56.7-26.5-24.9-25.5-9.3-22.4-18
Reconciled Cost Of Rev. Ann.
5.6%
15%
72.564.856.558.255.141.332.234.725.1179.7
Reconciled Depr. Ann.
34.7%
23.2%
10.710.57.64.94.34.13.73.32.81.90.6
Profit From Continuing Operations Ann.
-
-
-38.9-51.1-84.6-78.5-75.2-41.1-38.1-38.2-21.1-34.9-22.2
Normalized EBITDA Ann.
-
-
-9.2-22.3-56.2-58.3-38.4-27.3-26.9-28.9-23.4-20-15.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
27.2%
2Y CAGR
13%
3Y CAGR
9.3%
5Y CAGR
20%
7Y CAGR
19.3%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
16.2%
2Y CAGR
3.8%
3Y CAGR
8.2%
5Y CAGR
18.2%
7Y CAGR
17.5%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Establishment Labs Holdings Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Establishment Labs Holdings Inc Dec-2025 Total Shareholders Fund is $24 Million which is growth of -55.7% YoY.

  • POSITIVE

    Total Assets Establishment Labs Holdings Inc Dec-2025 Total Assets is $357 Million which is growth of 3.0% YoY.

Establishment Labs Holdings Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16
⌄
19.2%
18%
357.2346.8268.6211.1139.5156.4116.5116.657.129.6
⌄
15%
32.6%
333.6293.7250.3219.388.881.476.947.162.156
⌄
-
-20.6%
23.653.118.4-8.250.77539.669.5-5-26.4
Total Capitalization Ann.
17.5%
16.8%
271.1272.7207.1167.3102.6124.887.891.8-5-26.4
Tangible Assets Ann.
-
-29.3%
12.440.29.9-13.345.970.435.765.6-8.9-28.8
Working Capital Ann.
14.8%
9.5%
167.8174.8117.8110.981.4106.472.683-18.1-42.1
Invested Capital Ann.
19.2%
17.8%
283.5272.7207.1167.3102.6124.887.891.819.111.7
Tangible Book Value Ann.
-
-29.3%
12.440.29.9-13.345.970.435.765.6-8.9-28.8
Borrowings Ann.
13.8%
38.1%
264.5225.3192.2179.454.252.748.422.324.138.2
Net Debt Ann.
19.1%
-
184.4129.2148.7109.1--10.5-13.237.7
Share Issued Ann.
6.2%
4.4%
29.729.226.524.824.523.921.120.718.518.5
Number Of Shares End
6.6%
4.7%
29.82926.124.624.223.720.72115.4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
3%
2Y CAGR
15.3%
3Y CAGR
19.2%
5Y CAGR
18%
7Y CAGR
17.3%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
20.2%
2Y CAGR
19.8%
3Y CAGR
28.2%
5Y CAGR
26%
7Y CAGR
25.8%
Total Current Liabilities Annual Cr growth is lower than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-55.6%
2Y CAGR
13.3%
5Y CAGR
-20.6%
7Y CAGR
-14.3%
Total ShareHolders Funds Annual is falling faster than historical averages.

Establishment Labs Holdings Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Establishment Labs Holdings Inc Book Value Per Share is $1 which is growth of -7.7% YoY.

  • NEUTRAL

    ROE Establishment Labs Holdings Inc ROE is 0% which is growth of 0% YoY.

Establishment Labs Holdings Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16
RoA Ann. %
-
-
--27.49%-32.73%-42.90%-27.80%-27.94%-32.73%-24.30%-80.54%-74.96%
ROE Ann. %
-
-
--236.67%-1,537.75%-353.48%-65.46%-66.54%-69.94%-65.45%--
ROIC %
-
-
--11.4-8--11.5-2.8-4.6-9.5--
OPM Ann. %
-
-
-18.48%-30.11%-39.37%-24.53%-19.84%-32.97%-34.55%-38.99%-57.62%-79.96%
Inventory Turnover Ratio Ann.
-
-
-0.711.71.61.21.31.31.92
Asset Turnover Ann. %
-
-
-0.50.70.90.90.60.80.70.80.7
Working Capital Turnover Ann.
-4.7%
10.2%
1.311.41.51.60.81.20.7-1.9-0.5
Quick Ratio Ann.
-
-
-2.31.52.62.442.64.30.40.1
Current Ratio Ann.
-
-
-3.63.13.93.65.14.16.10.70.2
Interest Coverage Ratio Ann.
-
-
--3.1-4.1-5.2-3.4-3.1-3.3-1.4-2.3-5.5
LT Debt To Equity Ann.
-
-
-4.210.4-1.10.71.20.3--
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Establishment Labs Holdings Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Establishment Labs Holdings Inc Dec-2025 Cash From Operating Activity is $-51 Million which is growth of 13.0% YoY.

  • NEGATIVE

    Net Cash Flow Establishment Labs Holdings Inc Dec-2025 Net Cash Flow is $-17 Million which is growth of -133.8% YoY.

Establishment Labs Holdings Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16
⌄
-
-
-50.9-58.5-88.5-52.2-27.5-12.5-30-33.9-32-14.3
⌄
-
-
-7-15.6-24.6-34.8-7.2-5.6-7.8-5.7-0.8-10.8
⌄
-26.1%
-9%
40.4125.986.2100.34.164.722.881.54320.2
Cash Plus Cash Eqv. End Of Year Ann.
4.4%
-2.2%
75.690.44066.453.484.537.752.610.90.5
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-17.551.8-26.813.3-30.646.6-1541.910.2-4.8
Cash Plus Cash Eqv. Begin Of Year Ann.
19.2%
19.1%
90.44066.453.484.537.752.610.90.55.3
Income Tax Paid Supplemental Data Ann.
-42.5%
5.9%
0.41.72.22.10.70.30.70.10.2
Interest Paid Supplemental Data Ann.
56%
24%
20.59.85.75.46.9765.42.90.5
Capex Ann.
-
-
-6.7-15.6-24.6-34.3-6.7-3.9-7-1.8-0.9-10.6
Issuance Of Capital Stock Ann.
-
-
99.584.563.987.627.8
Issuance Of Debt Ann.
-41%
-
34.524.5168.1-24.838.525.1
Repayment Of Debt Ann.
-
-
-1-71.7-0.2-0.3-0.2-5.4-15.5-1.6
Repurchase Of Capital Stock Ann.
-
-
--------4.5-2
Free Cash Flow Ann.
-
-
-57.6-74.1-113.1-86.4-34.3-16.4-37-35.7-32.9-24.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-67.9%
2Y CAGR
-31.5%
3Y CAGR
-26.1%
5Y CAGR
-9%
7Y CAGR
-9.5%
Cash from Financing Annual Activity is falling faster than historical averages.
×